Archive for January, 2008
Rush University Medical Center To Utilize Radio Frequency Identification Technology From Mobile Aspects
Mobile Aspects announced that the Center for Congenital and Structural Heart Disease (CCSHD) at Rush University Medical Center, Chicago, has agreed to install iRISupply™, a clinical resource management system that manages medical devices and supplies through radio frequency identification (RFID) t…
Integration Of Host Tissue With Implants Boosted By Porous Structures
Results published in FASEB (the journal of the Federation of American Societies for Experimental Biology) by researchers at Columbia University, including Jeremy Mao of the Columbia College of Dental Medicine, demonstrate a novel way of using porous structures as a drug-delivery vehicle that can hel…
Learning And Memory Modulated By Newborn Brain Cells
Boosted by physical and mental exercise, neural stem cells continue to sprout new neurons all through life, but the exact operate of these newcomers has been the topic of much debate. Removing a genetic master switch that maintains neural stem cells in their proliferative state finally gave research…
Heart Attack Response And Cardiac Damage Predicted By Gene
A protein has been found that influences the response of the heart to a lack of oxygen and blood flow, such as occurs during a heart attack, a team of Yale School of Medicine researchers report in Nature.
This finding may present a new therapeutic approach to treating loss of blood flow and oxygen …
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) For LibiGel(R) In FSD
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced that it successfully has completed and reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for its Phase III safety and efficacy clinical trials for LibiGel (transdermal testost…
Medtronic Announces FDA Approval Of CGMS(R) IPRO(TM) continual Glucose Recorder
Medtronic, Inc. (NYSE: MDT) announced the FDA approval of a new physician-use continual glucose monitoring (CGM) system, the CGMS® iPro™ Recorder. Physicians send patients home with the CGMS iPro Recorder to uncover patterns and potential problems that often go undetected with today’s stand…
Tranzyme Pharma Receives IND Clearance For Its Oral Ghrelin Agonist, TZP-102, For The Treatment Of Gastroparesis
Tranzyme Pharma announced that the US Food and Drug Administration (FDA) completed its review of the Company’s Investigational New Drug (IND) application for TZP-102, Tranzyme’s second drug candidate to reach clinical development.
Tranzyme is a clinical stage company developing small mo…
